Clinical trial
Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel
NCT02366949
Study timeline
Study start (actual)2015-02-27Date precision: day
Registry last updated2020-04-07
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Medical Oncologyunresolved
Interventions
BAY1217389DRUG
PaclitaxelDRUG · verified · RxNorm: paclitaxel
Sponsors & collaborators
Bayerlead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02366949 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.